ArticleBiology of reproduction2026
A feeder-free culture system supports long-term expansion and germline competence of bovine formative embryonic stem cells†.
Article in Biology of reproduction, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Production of gene-edited cloned cattle embryos using the CRISPR/EOCas12i system.Frontiers in genome editing · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Bovine embryonic stem cells (bESCs) are a cornerstone for next-generation applications such as cell-cultured meat, large-animal gene editing, and embryo-stem cell breeding systems. Although primed bESCs and bovine expanded potential stem cells have recently been established, their routine maintenance commonly relies on mouse embryonic fibroblast or bovine fetal fibroblast feeder layers, which are complex, labor-intensive, poorly standardized, and incompatible with scalable manufacturing. Here, we report a simplified feeder-free culture platform for bESCs in which a commercially available basal medium is combined with Growth Factor Reduced Matrigel to generate a three-dimensional, niche-mimetic substrate. Using this approach, we successfully derived a novel feeder-free bESCs (FF-bESCs) that can be robustly expanded for more than 60 passages without ROCK inhibitors, while maintaining a normal karyotype, high proliferation rates, and stable expression of core pluripotency markers. Functional assays confirmed that FF-bESCs possess bona fide pluripotency, as evidenced by their ability to form embryoid bodies in vitro and generate teratomas containing derivatives of all three germ layers in vivo. Transcriptomic profiling further revealed that FF-bESCs align with a formative pluripotent state. Notably, these cells can be directed to differentiate into primordial germ cell-like cells. Our feeder-free culture system provides a scalable, reproducible foundation for advancing bESC-based technologies in bovine precision genome editing and germ cell differentiation for embryo-stem cell breeding systems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.